| Skip To Content | ||||||
|
|
|
|
|
|
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
![]() |
J. Michael Walsh, Ph.D. |
||
|
In this eBriefing, J. Michael Walsh, Ph.D., President of The Walsh Group, PA, and former Executive Director of the President's Drug Advisory Council, provides a historical and political perspective of the evolution over the past two decades of Federally-regulated drug testing. The shift of major corporations from a philosophy of punitive measures to support for prevention/rehabilitation is discussed. Currently Dr. Walsh is the Principal Investigator for a 3-year study funded by the Division of Workplace Programs, Center for Substance Abuse Prevention. This study is a strategic partnership with a major technology manufacturing corporation. Contact: jmwalsh@walshgroup.org (301)-571-9494 |
|||
| Watch: 28k T1 |
Recorded: 2/17/00
|
Runtime: 10m01s
|
|
| Having problems watching? Click here for help | |||